Behner Peter's most recent trade in MiNK Therapeutics Inc was a trade of 1,849 Common Stock done at an average price of $8.8 . Disclosure was reported to the exchange on March 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
MiNK Therapeutics Inc | Peter Behner | Director | Grant, award, or other acquisition of securities at price $ 8.79 per share. | 03 Mar 2025 | 1,849 | 15,209 | - | 8.8 | 16,253 | Common Stock |
MiNK Therapeutics Inc | Peter Behner | Director | Grant, award, or other acquisition of securities at price $ 0.73 per share. | 01 Dec 2024 | 20,987 | 133,634 | - | 0.7 | 15,321 | Common Stock |
MiNK Therapeutics Inc | Peter Behner | Director | Grant, award, or other acquisition of securities at price $ 0.82 per share. | 03 Sep 2024 | 18,753 | 109,234 | - | 0.8 | 15,377 | Common Stock |
MiNK Therapeutics Inc | Peter Behner | Director | Grant, award, or other acquisition of securities at price $ 0.99 per share. | 03 Jun 2024 | 15,454 | 90,481 | - | 1.0 | 15,299 | Common Stock |
MiNK Therapeutics Inc | Peter Behner | Director | Grant, award, or other acquisition of securities at price $ 0.95 per share. | 01 Mar 2024 | 16,185 | 75,027 | - | 1.0 | 15,376 | Common Stock |
MiNK Therapeutics Inc | Behner Peter | Director | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 01 Dec 2023 | 14,784 | 58,842 | - | 1.0 | 15,375 | Common Stock |
MiNK Therapeutics Inc | Peter Behner | Director | Grant, award, or other acquisition of securities at price $ 2.09 per share. | 01 Mar 2023 | 7,357 | 24,985 | - | 2.1 | 15,376 | Common Stock |
MiNK Therapeutics Inc | Peter Behner | Director | Grant, award, or other acquisition of securities at price $ 2.61 per share. | 01 Dec 2022 | 5,891 | 17,628 | - | 2.6 | 15,376 | Common Stock |
MiNK Therapeutics Inc | Peter Behner | Director | Grant, award, or other acquisition of securities at price $ 2.62 per share. | 15 Sep 2022 | 11,737 | 11,737 | - | 2.6 | 30,751 | Common Stock |
MiNK Therapeutics Inc | Peter Behner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) |